We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Nonhospitalized patients with COVID-19 who received the ...

At all Walgreens locations, Alvesco will be available at no cost or reduced cost to eligible patients “Asthma is one of the country’s most common diseases, impacting 25 million individuals across the ...

Alvesco approved for asthma Sepracor has launched Alvesco (ciclesonide) inhalation aerosol for the prophylactic and maintenance treatment of asthma in patients ≥12 years of age. Sepracor has launched ...

Germany’s Altana has provided fresh evidence that its inhaled corticosteroid Alvesco (ciclesonide) is free of the systemic side effects thought to affect other drugs in this class. Germany’s Altana ...

Active ingredient: Ciclesonide 80 µg/inhalation, 160 µg/inhalation; metered-dose inhaler. Indication: Maintenance treatment of asthma as prophylactic therapy in patients >12 years of age. Pharmacology ...

Alvesco approved for asthma The FDA has approved Alvesco (ciclesonide, from Nycomed) inhalation aerosol for the prophylactic and maintenance treatment of asthma in patients ≥12 years of age. The FDA ...

ZUG, Switzerland, April 15, 2021 (GLOBE NEWSWIRE) -- Covis Pharma Group (the “Company”), a global specialty pharmaceutical company that markets therapeutic solutions for patients with life-threatening ...

ZURICH (Reuters) - Unlisted Covis Pharma B.V. started a late-stage U.S. randomized trial of its asthma drug Alvesco in non-hospitalized patients with symptomatic COVID-19, hoping the inhaled drug ...

Type: Inhaled glucocorticoid with a small particle size (1-2 μm) enabling it to reach areas of chronic inflammation in both the large and small airways. Alvesco is indicated for the long-term ...

U.S. Food and Drug Administration (FDA) has approved the company's Investigational New Drug (IND) filing to study the use of Alvesco in COVID-19 Study will evaluate the Safety and Efficacy of Alvesco ...

Denmark’s Nycomed has told PharmaTimes World News it has reached an “amicable and mutual” agreement with partner Sanofi-Aventis which sees the former firm take back marketing rights in the USA to the ...

ZUG, Switzerland--(BUSINESS WIRE)--Covis Pharma B.V. (“Covis Pharma”), a global specialty pharmaceutical company, is pleased to announce an agreement with Walgreens, one of the largest drugstore ...